James E. Flynn 13D/13G Filings for Inozyme Pharma, Inc. (INZY)

James E. Flynn 13D and 13G filings for Inozyme Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-10
10:03 am
Sale		2022-12-3113GInozyme Pharma, Inc.
INZY		James E. Flynn0
0.000%		-2,344,786decrease
(Position Closed)		Filing
2022-02-11
4:37 pm
Purchase		2021-12-3113GInozyme Pharma, Inc.
INZY		James E. Flynn2,344,786
9.910%		1,194,487increase
(+103.84%)		Filing
2020-08-06
10:58 am
Purchase		2020-07-2813GInozyme Pharma, Inc.
INZY		James E. Flynn1,150,299
5.150%		1,150,299increase
(New Position)		Filing